Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.34 |
| ▸ | ABAT | P80404 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1915245 | 0.95 | KMT2A (0.41) | KMT2ACHRM2CHRM3LMNACYP2D6 | |
| SCHEMBL1915600 | 0.94 | KMT2A (0.41) | KMT2ACHRM2CHRM3LMNACYP2D6 | |
| SCHEMBL28118917 | 0.81 | CHRM3 (0.42) | CHRM2CHRM3LMNACYP2D6CHRM1 | |
| SCHEMBL1916611 | 0.81 | PARP10 (0.39) | KMT2ACHRM2CHRM3LMNACYP2D6 | |
| SCHEMBL28063826 | 0.80 | CHRM2 (0.41) | CHRM2CHRM3LMNACYP2D6CHRM1 | |
| SCHEMBL4138872 | 0.80 | CHRM3 (0.54) | KMT2ACHRM2CHRM3LMNACYP2D6 | |
| SCHEMBL1915397 | 0.77 | KMT2A (0.39) | KMT2AEPHX2NR1H4ALDH1A1ALDH5A1 | |
| SCHEMBL28063823 | 0.77 | KIF11 (0.40) | CHRM2CHRM3LMNACYP2D6CHRM1 | |
| SCHEMBL28118919 | 0.75 | CHRM2 (0.40) | CHRM2CHRM3LMNACYP2D6CHRM1 | |
| SCHEMBL20543316 | 0.74 | SMN1; SMN2 (0.45) | KMT2AKDM4EEPHX2NR1H4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130018140-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKING AGENTS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | DICKMEIS MARCUS (DE) | 2013-01-17 | — | — | US | disclosed |
| EP-2516531-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKERS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | Dickmeis, Marcus (DE) | 2012-10-31 | — | — | EP | disclosed |
| EP-2516532-A2 | POLYOXAZIRIDINES AND USE THEREOF AS A CROSS-LINKING AGENT, ESPECIALLY IN COATING MATERIALS AND ADHESIVES | Dickmeis, Marcus (DE) | 2012-10-31 | — | — | EP | disclosed |
| WO-2011085793-A2 | POLYOXAZIRIDINES AND USE THEREOF AS A CROSS-LINKING AGENT, ESPECIALLY IN COATING MATERIALS AND ADHESIVES | DICKMEIS MARCUS (DE) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011076392-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKERS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | DICKMEIS MARCUS (DE) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018140-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKING AGENTS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | PNN, PARN, NCLN | KMT2A 631/4885CHRM2 974/4885CHRM3 1178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.